Recent Finacing
Recent Raise
OncoResponse is clinical-stage immuno-oncology firm using a proprietary human B‑cell discovery platform to identify fully human monoclonal antibodies that target immunosuppressive myeloid/macrophage pathways, partnered with MD Anderson.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
